Recent progress in dengue vaccine development.

about

Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study.Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

P2860

Q35742387-2D691055-A02A-469F-957D-156ABBBC19FA Q38614539-DB4529F7-8A9F-4274-B21D-BCA624977DDE

P2860

Recent progress in dengue vaccine development.

Item

http://www.wikidata.org/entity/Q38303232

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Recent progress in dengue vaccine development.

@en

type

Item

label

Recent progress in dengue vaccine development.

@en

prefLabel

Recent progress in dengue vaccine development.

@en

P1476

Recent progress in dengue vaccine development.

@en

P2093

Hui Chen

http://www.w3.org/2001/XMLSchema#string

Jianchun Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Surprising New Dengue Virus Throws a Spanner in Disease Control Efforts

The global distribution and burden of dengue

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

Understanding the dengue viruses and progress towards their control

Latest developments and future directions in dengue vaccines

Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

P2888

s12250-014-3542-7

P304

353-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12250-014-3542-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jing An

P577

2014-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030551571

http://www.w3.org/2001/XMLSchema#string

P698

25547681

http://www.w3.org/2001/XMLSchema#string

P921

Dengue virus

Recent progress in dengue vaccine development.

about

P2860

P2860

Recent progress in dengue vaccine development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921